D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Immunology D-index 60 Citations 13,587 188 World Ranking 2339 National Ranking 1125

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Disease
  • Gene

Cem Akin spends much of his time researching Immunology, Systemic mastocytosis, Mast cell, Mast cell leukemia and Urticaria pigmentosa. His Immunology study deals with Internal medicine intersecting with Oncology. His Cutaneous Mastocytosis study, which is part of a larger body of work in Systemic mastocytosis, is frequently linked to Population, bridging the gap between disciplines.

His study in Mast cell is interdisciplinary in nature, drawing from both Molecular biology and Stem cell factor. Cem Akin has included themes like Cancer research, Imatinib, Midostaurin and Kinase activity in his Mast cell leukemia study. His work deals with themes such as Eosinophilia, Hypereosinophilic syndrome, Disease and Histamine, which intersect with Tryptase.

His most cited work include:

  • Diagnostic criteria and classification of mastocytosis: a consensus proposal (853 citations)
  • Standards and standardization in mastocytosis: consensus statements on diagnostics, treatment recommendations and response criteria. (558 citations)
  • Characterization of novel stem cell factor responsive human mast cell lines LAD 1 and 2 established from a patient with mast cell sarcoma/leukemia; activation following aggregation of FcεRI or FcγRI (411 citations)

What are the main themes of his work throughout his whole career to date?

The scientist’s investigation covers issues in Immunology, Systemic mastocytosis, Mast cell, Tryptase and Internal medicine. His Immunology research is multidisciplinary, incorporating perspectives in Haematopoiesis and Disease. Cem Akin frequently studies issues relating to Urticaria pigmentosa and Systemic mastocytosis.

His Mast cell study also includes fields such as

  • Mast cell activation syndrome which is related to area like Intensive care medicine,
  • Tyrosine kinase together with Proto-Oncogene Proteins c-kit. His research in Tryptase intersects with topics in Mast cell activation, Immunopathology and Histamine. His research integrates issues of Gastroenterology and Oncology in his study of Internal medicine.

He most often published in these fields:

  • Immunology (57.39%)
  • Systemic mastocytosis (54.78%)
  • Mast cell (37.83%)

What were the highlights of his more recent work (between 2017-2021)?

  • Systemic mastocytosis (54.78%)
  • Mast cell (37.83%)
  • Mast cell activation syndrome (14.35%)

In recent papers he was focusing on the following fields of study:

Systemic mastocytosis, Mast cell, Mast cell activation syndrome, Immunology and Tryptase are his primary areas of study. His work in the fields of Systemic mastocytosis, such as Cutaneous Mastocytosis and Kit d816v, overlaps with other areas such as In patient. In the field of Mast cell, his study on Mast cell leukemia overlaps with subjects such as Diagnostic methods.

His Mast cell activation syndrome research includes elements of Bronchoconstriction, Medical diagnosis, Abdominal pain and Bioinformatics. His Immunology study combines topics in areas such as Patient perceptions and Histamine. His studies in Tryptase integrate themes in fields like Somatic cell, Bone marrow and Midostaurin.

Between 2017 and 2021, his most popular works were:

  • Proposed Diagnostic Algorithm for Patients with Suspected Mast Cell Activation Syndrome. (59 citations)
  • Why the 20% + 2 Tryptase Formula Is a Diagnostic Gold Standard for Severe Systemic Mast Cell Activation and Mast Cell Activation Syndrome. (23 citations)
  • Multidisciplinary Challenges in Mastocytosis and How to Address with Personalized Medicine Approaches. (21 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Disease
  • Gene

Cem Akin mostly deals with Systemic mastocytosis, Mast cell activation syndrome, Tryptase, Mast cell and Anaphylaxis. His study on Systemic mastocytosis is covered under Disease. He combines subjects such as Medical diagnosis, Cutaneous Mastocytosis and Bioinformatics with his study of Mast cell activation syndrome.

His Tryptase study necessitates a more in-depth grasp of Immunology. His Immunology research incorporates elements of Phenotype and Progenitor cell. His research in Mast cell is mostly focused on Mast cell leukemia.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Diagnostic criteria and classification of mastocytosis: a consensus proposal

Peter Valent;Hans P. Horny;Luis Escribano;B. Jack Longley.
Leukemia Research (2001)

1245 Citations

Standards and standardization in mastocytosis: consensus statements on diagnostics, treatment recommendations and response criteria.

P. Valent;C. Akin;L. Escribano;M. Födinger.
European Journal of Clinical Investigation (2007)

838 Citations

Characterization of novel stem cell factor responsive human mast cell lines LAD 1 and 2 established from a patient with mast cell sarcoma/leukemia; activation following aggregation of FcεRI or FcγRI

Arnold S. Kirshenbaum;Cem Akin;Yalin Wu;Menachem Rottem.
Leukemia Research (2003)

673 Citations

The c-KIT mutation causing human mastocytosis is resistant to STI571 and other KIT kinase inhibitors; kinases with enzymatic site mutations show different inhibitor sensitivity profiles than wild-type kinases and those with regulatory-type mutations.

Yongsheng Ma;Shan Zeng;Dean D. Metcalfe;Cem Akin.
Blood (2002)

608 Citations

Definitions, Criteria and Global Classification of Mast Cell Disorders with Special Reference to Mast Cell Activation Syndromes: A Consensus Proposal

Peter Valent;Cem Akin;Michel Arock;Knut Brockow.
International Archives of Allergy and Immunology (2012)

554 Citations

Mastocytosis: 2016 updated WHO classification and novel emerging treatment concepts

Peter Valent;Cem Akin;Dean D. Metcalfe.
Blood (2017)

499 Citations

Elevated serum tryptase levels identify a subset of patients with a myeloproliferative variant of idiopathic hypereosinophilic syndrome associated with tissue fibrosis, poor prognosis, and imatinib responsiveness.

Amy D. Klion;Amy D. Klion;Pierre Noel;Pierre Noel;Cem Akin;Cem Akin;Melissa A. Law;Melissa A. Law.
Blood (2003)

492 Citations

Mast Cells, Mastocytosis, and Related Disorders

Theoharis C. Theoharides;Peter Valent;Cem Akin.
The New England Journal of Medicine (2015)

433 Citations

A novel form of mastocytosis associated with a transmembrane c-kit mutation and response to imatinib

Cem Akin;Gerard Fumo;Akif S. Yavuz;Peter E. Lipsky.
Blood (2004)

414 Citations

Efficacy and Safety of Midostaurin in Advanced Systemic Mastocytosis

Jason Gotlib;Hanneke C. Kluin-Nelemans;Tracy I. George;Cem Akin.
The New England Journal of Medicine (2016)

363 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Cem Akin

Peter Valent

Peter Valent

Medical University of Vienna

Publications: 206

Olivier Hermine

Olivier Hermine

Université Paris Cité

Publications: 91

Dean D. Metcalfe

Dean D. Metcalfe

National Institute of Allergy and Infectious Diseases

Publications: 88

Theoharis C. Theoharides

Theoharis C. Theoharides

Nova Southeastern University

Publications: 86

Luis Escribano

Luis Escribano

University of Salamanca

Publications: 72

Patrice Dubreuil

Patrice Dubreuil

Inserm

Publications: 65

Jason Gotlib

Jason Gotlib

Stanford University

Publications: 61

Alberto Orfao

Alberto Orfao

University of Salamanca

Publications: 56

Animesh Pardanani

Animesh Pardanani

Mayo Clinic

Publications: 52

Ayalew Tefferi

Ayalew Tefferi

Mayo Clinic

Publications: 50

Nicholas C.P. Cross

Nicholas C.P. Cross

University of Southampton

Publications: 50

Gunnar Nilsson

Gunnar Nilsson

Karolinska Institute

Publications: 46

Mariana Castells

Mariana Castells

Brigham and Women's Hospital

Publications: 41

Knut Brockow

Knut Brockow

Technical University of Munich

Publications: 41

Srdan Verstovsek

Srdan Verstovsek

The University of Texas MD Anderson Cancer Center

Publications: 33

Joseph H. Butterfield

Joseph H. Butterfield

Mayo Clinic

Publications: 31

Trending Scientists

Dong Yu

Dong Yu

Tencent (China)

Reiko Heckel

Reiko Heckel

University of Leicester

Themistocles M. Rassias

Themistocles M. Rassias

National Technical University of Athens

Cheng Zhong

Cheng Zhong

Wuhan University

Martin A. Suhm

Martin A. Suhm

University of Göttingen

Babak Kakavandi

Babak Kakavandi

Ahvaz Jundishapur University of Medical Sciences

Christopher R. Lowe

Christopher R. Lowe

University of Cambridge

Charles H. Daugherty

Charles H. Daugherty

Victoria University of Wellington

Stéphane Méresse

Stéphane Méresse

Centre d’Immunologie de Marseille-Luminy

JoAnne S. Richards

JoAnne S. Richards

Baylor College of Medicine

Richard Kempter

Richard Kempter

Humboldt-Universität zu Berlin

Roz Shafran

Roz Shafran

University College London

Sapna Syngal

Sapna Syngal

Harvard Medical School

Frank L. Meyskens

Frank L. Meyskens

University of California, Irvine

Andrew W. Roberts

Andrew W. Roberts

Walter and Eliza Hall Institute of Medical Research

Dylan Wiliam

Dylan Wiliam

University College London

Something went wrong. Please try again later.